This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hansen, L. A. Articles by Yuspa, S. H. Search for Related Content PubMed PubMed Citation Articles by Hansen, L. A. Articles by Yuspa, S. H.

The Epidermal Growth Factor Receptor Is Required to Maintain the Proliferative Population in the Basal Compartment of Epidermal Tumors

Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland 20892

Previous studies using keratinocytes from epidermal growth factor receptor (EGFR)-deficient mice revealed that the EGFR is not required for papilloma formation initiated by a mutant ras^Ha gene, although the tumors that develop are very small (A. A. Dlugosz et al., Cancer Res., 57: 3180–3188, 1997). The current study used a combination of bromodeoxyuridine pulse-chase, proliferating cell nuclear antigen distribution, and differentiation marker analysis to reveal the following: (a) the EGFR was required to maintain the proliferative population in the basal cell compartment of papillomas; (b) in the absence of EGFR, cycling tumor cells migrated into the suprabasal compartment and initiated the differentiation program prematurely; and (c) these changes were associated with cell cycle arrest. Further analysis of v-ras^Ha-transformed EGFR-deficient keratinocytes in vitro indicated that such cells migrated more on and attached less to extracellular matrix components. Together, these studies reveal that an essential function for the EGFR pathway in squamous tumors is to maintain a proliferative pool of basal cells and prevent premature terminal differentiation.

This article has been cited by other articles:

				C. Cataisson, R. Ohman, G. Patel, A. Pearson, M. Tsien, S. Jay, L. Wright, H. Hennings, and S. H. Yuspa Inducible Cutaneous Inflammation Reveals a Protumorigenic Role for Keratinocyte CXCR2 in Skin Carcinogenesis Cancer Res., January 1, 2009; 69(1): 319 - 328. [Abstract] [Full Text] [PDF]

				M. R. Schneider, S. Werner, R. Paus, and E. Wolf Beyond Wavy Hairs: The Epidermal Growth Factor Receptor and Its Ligands in Skin Biology and Pathology Am. J. Pathol., July 1, 2008; 173(1): 14 - 24. [Abstract] [Full Text] [PDF]

				J. Lu, O. Rho, E. Wilker, L. Beltran, and J. DiGiovanni Activation of Epidermal Akt by Diverse Mouse Skin Tumor Promoters Mol. Cancer Res., December 1, 2007; 5(12): 1342 - 1352. [Abstract] [Full Text] [PDF]

				D. Brennan, Y. Hu, S. Joubeh, Y. W. Choi, D. Whitaker-Menezes, T. O'Brien, J. Uitto, U. Rodeck, and M. G. Mahoney Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes J. Cell Sci., March 1, 2007; 120(5): 758 - 771. [Abstract] [Full Text] [PDF]

				T. B. El-Abaseri, S. Putta, and L. A. Hansen Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor Carcinogenesis, February 1, 2006; 27(2): 225 - 231. [Abstract] [Full Text] [PDF]

				K.E. King, R.M. Ponnamperuma, M.J. Gerdes, T. Tokino, T. Yamashita, C.C. Baker, and W.C. Weinberg Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis Carcinogenesis, January 1, 2006; 27(1): 53 - 63. [Abstract] [Full Text] [PDF]

				C. V. Lund, M. Popkov, L. Magnenat, and C. F. Barbas III Zinc Finger Transcription Factors Designed for Bispecific Coregulation of ErbB2 and ErbB3 Receptors: Insights into ErbB Receptor Biology Mol. Cell. Biol., October 15, 2005; 25(20): 9082 - 9091. [Abstract] [Full Text] [PDF]

				W. Li, C. Marshall, L. Mei, L. Dzubow, C. Schmults, M. Dans, and J. Seykora Srcasm Modulates EGF and Src-kinase Signaling in Keratinocytes J. Biol. Chem., February 18, 2005; 280(7): 6036 - 6046. [Abstract] [Full Text] [PDF]

				F. Mascia, V. Mariani, G. Girolomoni, and S. Pastore Blockade of the EGF Receptor Induces a Deranged Chemokine Expression in Keratinocytes Leading to Enhanced Skin Inflammation Am. J. Pathol., July 1, 2003; 163(1): 303 - 312. [Abstract] [Full Text] [PDF]

				D. B. Willis and N. H. Colburn Molecular Targets for Cancer Prevention: A Meeting Review of the Third American Cancer Society-Schilling Research Conference Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 972 - 978. [Abstract] [Full Text] [PDF]

				C. J. Conti Vascular Endothelial Growth Factor: Regulation in the Mouse Skin Carcinogenesis Model and Use in Antiangiogenesis Cancer Therapy Oncologist, August 1, 2002; 7(90003): 4 - 11. [Abstract] [Full Text] [PDF]

				H. F. Tiano, C. D. Loftin, J. Akunda, C. A. Lee, J. Spalding, A. Sessoms, D. B. Dunson, E. G. Rogan, S. G. Morham, R. C. Smart, et al. Deficiency of Either Cyclooxygenase (COX)-1 or COX-2 Alters Epidermal Differentiation and Reduces Mouse Skin Tumorigenesis Cancer Res., June 1, 2002; 62(12): 3395 - 3401. [Abstract] [Full Text] [PDF]

				R. B. Roberts, L. Min, M. K. Washington, S. J. Olsen, S. H. Settle, R. J. Coffey, and D. W. Threadgill Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis PNAS, January 24, 2002; (2002) 32678499. [Abstract] [Full Text] [PDF]

				J. Albanell, F. Rojo, S. Averbuch, A. Feyereislova, J. M. Mascaro, R. Herbst, P. LoRusso, D. Rischin, S. Sauleda, J. Gee, et al. Pharmacodynamic Studies of the Epidermal Growth Factor Receptor Inhibitor ZD1839 in Skin From Cancer Patients: Histopathologic and Molecular Consequences of Receptor Inhibition J. Clin. Oncol., January 1, 2002; 20(1): 110 - 124. [Abstract] [Full Text] [PDF]

				R. B. Roberts, L. Min, M. K. Washington, S. J. Olsen, S. H. Settle, R. J. Coffey, and D. W. Threadgill Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis PNAS, February 5, 2002; 99(3): 1521 - 1526. [Abstract] [Full Text] [PDF]